127 related articles for article (PubMed ID: 27258201)
61. DCE-MRI for Pre-Treatment Prediction and Post-Treatment Assessment of Treatment Response in Sites of Squamous Cell Carcinoma in the Head and Neck.
King AD; Chow SK; Yu KH; Mo FK; Yeung DK; Yuan J; Law BK; Bhatia KS; Vlantis AC; Ahuja AT
PLoS One; 2015; 10(12):e0144770. PubMed ID: 26657972
[TBL] [Abstract][Full Text] [Related]
62. Angiogenesis is redundant for tumour growth in lymph node metastases.
Naresh KN; Nerurkar AY; Borges AM
Histopathology; 2001 May; 38(5):466-70. PubMed ID: 11422485
[TBL] [Abstract][Full Text] [Related]
63. Diagnostic value of 3D dynamic contrast-enhanced magnetic resonance imaging in lymph node metastases of head and neck tumors: a correlation study with histology.
Treutlein C; Stollberg A; Scherl C; Agaimy A; Ellmann S; Iro H; Lell M; Uder M; Bäuerle T
Acta Radiol Open; 2020 Aug; 9(8):2058460120951966. PubMed ID: 32922960
[TBL] [Abstract][Full Text] [Related]
64. Photoacoustic Molecular Imaging for the Identification of Lymph Node Metastasis in Head and Neck Cancer Using an Anti-EGFR Antibody-Dye Conjugate.
Nishio N; van den Berg NS; Martin BA; van Keulen S; Fakurnejad S; Rosenthal EL; Wilson KE
J Nucl Med; 2021 May; 62(5):648-655. PubMed ID: 33008927
[TBL] [Abstract][Full Text] [Related]
65. Dynamic Contrast-Enhanced MR Perfusion in Differentiation of Benign and Malignant Brain Lesions.
Cetinkaya E; Aralasmak A; Atasoy B; Tokdemir S; Toprak H; Toprak A; Kurtcan S; Alkan A
Curr Med Imaging; 2022; 18(10):1099-1105. PubMed ID: 35331119
[TBL] [Abstract][Full Text] [Related]
66. Cervical nodal metastases from head and neck squamous cell carcinoma: MRI criteria for treatment assessment.
King AD; Yu KH; Mo FK; Law BK; Yuen TW; Bhatia KS; Vlantis AC
Head Neck; 2016 Apr; 38 Suppl 1():E1598-604. PubMed ID: 26875511
[TBL] [Abstract][Full Text] [Related]
67. The prognostic significance of metastatic cervical lymph nodes.
Schuller DE; McGuirt WF; McCabe BF; Young D
Laryngoscope; 1980 Apr; 90(4):557-70. PubMed ID: 7359975
[TBL] [Abstract][Full Text] [Related]
68. Correlation of a priori DCE-MRI and (1)H-MRS data with molecular markers in neck nodal metastases: Initial analysis.
Jansen JF; Carlson DL; Lu Y; Stambuk HE; Moreira AL; Singh B; Patel SG; Kraus DH; Wong RJ; Shaha AR; Shah JP; Shukla-Dave A
Oral Oncol; 2012 Aug; 48(8):717-22. PubMed ID: 22366441
[TBL] [Abstract][Full Text] [Related]
69. The correlations between dynamic contrast enhanced magnetic resonance imaging and immunohistochemical data in head and neck squamous cell carcinomas.
Karabay N; Bülbül HM; Doğan E; İkiz AÖ; Bülbül G; Sarıoğlu S
Turk J Med Sci; 2022 Dec; 52(6):1950-1957. PubMed ID: 36945990
[TBL] [Abstract][Full Text] [Related]
70. Shear wave elastography of lymph nodes in dogs with head and neck cancer: A pilot study.
Favril S; Stock E; Broeckx BJG; Devriendt N; de Rooster H; Vanderperren K
Vet Comp Oncol; 2022 Jun; 20(2):521-528. PubMed ID: 35080328
[TBL] [Abstract][Full Text] [Related]
71. Dynamic contrast-enhanced magnetic resonance imaging in Head and Neck Cancer: differentiation of new H&N cancer, recurrent disease, and benign post-treatment changes.
Ishiyama M; Richards T; Parvathaneni U; Anzai Y
Clin Imaging; 2015; 39(4):566-70. PubMed ID: 25778388
[TBL] [Abstract][Full Text] [Related]
72. Dynamic contrast-enhanced magnetic resonance imaging biomarkers in head and neck cancer: potential to guide treatment? A systematic review.
Bernstein JM; Homer JJ; West CM
Oral Oncol; 2014 Oct; 50(10):963-70. PubMed ID: 25116700
[TBL] [Abstract][Full Text] [Related]
73. Role of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameters and Extracellular Volume Fraction as Predictors of Lung Cancer Subtypes and Lymph Node Status in Non-Small-Cell Lung Cancer Patients.
Guo W; Lv B; Yang T; Tian M; Liu M; Lin X; Zhao P
J Cancer; 2023; 14(16):3108-3116. PubMed ID: 37859821
[No Abstract] [Full Text] [Related]
74. Diagnostic Value of Multimodal Magnetic Resonance Imaging in Discriminating Between Metastatic and Non-Metastatic Pelvic Lymph Nodes in Cervical Cancer.
Xu J; Ma Y; Mei H; Wang Q
Int J Gen Med; 2022; 15():6279-6288. PubMed ID: 35911622
[TBL] [Abstract][Full Text] [Related]
75. The Use of Dynamic Contrast-Enhanced Perfusion MRI in Differentiating Benign and Malignant Thyroid Nodules.
Sakat MS; Sade R; Kilic K; Gözeler MS; Pala O; Polat G; Kantarcı M
Indian J Otolaryngol Head Neck Surg; 2019 Oct; 71(Suppl 1):706-711. PubMed ID: 31742047
[TBL] [Abstract][Full Text] [Related]
76. Texture Analysis of Multi-Shot Echo-planar Diffusion-Weighted Imaging in Head and Neck Squamous Cell Carcinoma: The Diagnostic Value for Nodal Metastasis.
Park JH; Bae YJ; Choi BS; Jung YH; Jeong WJ; Kim H; Sunwoo L; Jung C; Kim JH
J Clin Med; 2019 Oct; 8(11):. PubMed ID: 31652840
[TBL] [Abstract][Full Text] [Related]
77. Use of dynamic MRI during swallowing to assess carotid artery invasion by neck metastasis.
Chitose SI; Ono T; Shin B; Sato K; Umeno H
Head Neck; 2018 Feb; 40(2):330-337. PubMed ID: 28960586
[TBL] [Abstract][Full Text] [Related]
78. Mechanisms of cyst formation in metastatic lymph nodes of head and neck squamous cell carcinoma.
Mokhtari S
Diagn Pathol; 2012 Jan; 7():6. PubMed ID: 22248307
[TBL] [Abstract][Full Text] [Related]
79. The Diagnostic Performance of Magnetic Resonance Imaging in the Categorization of Pediatric Neck Lymph Nodes: Radiologic and Pathologic Correlations.
Caliskan E; Paytoncu N; Düzkalır HG; Arifoglu M; Fistikcioglu N; Gunbey HP
J Pediatr Hematol Oncol; 2024 May; 46(4):188-196. PubMed ID: 38573005
[TBL] [Abstract][Full Text] [Related]
80. Deep Learning for the Preoperative Diagnosis of Metastatic Cervical Lymph Nodes on Contrast-Enhanced Computed ToMography in Patients with Oral Squamous Cell Carcinoma.
Tomita H; Yamashiro T; Heianna J; Nakasone T; Kobayashi T; Mishiro S; Hirahara D; Takaya E; Mimura H; Murayama S; Kobayashi Y
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33546279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
